Steven Zalcman

3.7k total citations · 1 hit paper
13 papers, 1.0k citations indexed

About

Steven Zalcman is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Biological Psychiatry. According to data from OpenAlex, Steven Zalcman has authored 13 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Psychiatry and Mental health, 3 papers in Cellular and Molecular Neuroscience and 3 papers in Biological Psychiatry. Recurrent topics in Steven Zalcman's work include Schizophrenia research and treatment (8 papers), Bipolar Disorder and Treatment (5 papers) and Tryptophan and brain disorders (3 papers). Steven Zalcman is often cited by papers focused on Schizophrenia research and treatment (8 papers), Bipolar Disorder and Treatment (5 papers) and Tryptophan and brain disorders (3 papers). Steven Zalcman collaborates with scholars based in United States and India. Steven Zalcman's co-authors include Daniel R. Weinberger, Jonathan D. Cohen, Robert S. Kern, Deanna M. Barch, Ellen Stover, Stephen R. Marder, Helena C. Kraemer, Keith H. Nuechterlein, Terry E. Goldberg and Richard S.E. Keefe and has published in prestigious journals such as JAMA, American Journal of Psychiatry and Biological Psychiatry.

In The Last Decade

Steven Zalcman

13 papers receiving 961 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Approaching a consensus cognitive battery for clinical trials in schizophrenia: The NIMH-MATRICS conference to select cognitive domains and test criteria

2004 702 citations Michael F. Green, Keith H. Nuechterlein et al. Biological Psychiatry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Steven Zalcman United States	11	639	284	196	192	166	13	1.0k
C Scharfetter Switzerland	14	367 0.6×	211 0.7×	221 1.1×	138 0.7×	203 1.2×	48	833
EveC. Johnstone United Kingdom	7	1.1k 1.8×	493 1.7×	308 1.6×	234 1.2×	185 1.1×	10	1.7k
Barringer D. Marshall United States	13	761 1.2×	244 0.9×	137 0.7×	220 1.1×	234 1.4×	31	942
Adrianne M. Reveley United Kingdom	15	541 0.8×	239 0.8×	114 0.6×	110 0.6×	230 1.4×	22	1.1k
D. G. C. Owens United Kingdom	15	838 1.3×	379 1.3×	135 0.7×	199 1.0×	192 1.2×	17	1.3k
R. W. Buchanan United States	8	690 1.1×	187 0.7×	89 0.5×	271 1.4×	170 1.0×	8	853
Michal Kunz United States	12	740 1.2×	306 1.1×	165 0.8×	115 0.6×	301 1.8×	17	1.1k
R.S.E. Keefe United States	14	1.2k 1.9×	536 1.9×	194 1.0×	435 2.3×	365 2.2×	23	1.6k
Lena Flyckt Sweden	20	608 1.0×	242 0.9×	226 1.2×	136 0.7×	293 1.8×	50	1.2k
Viljo Räkköläinen Finland	13	676 1.1×	337 1.2×	369 1.9×	173 0.9×	301 1.8×	23	1.1k

Countries citing papers authored by Steven Zalcman

Since Specialization

Citations

This map shows the geographic impact of Steven Zalcman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Zalcman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Zalcman more than expected).

Fields of papers citing papers by Steven Zalcman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Zalcman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Zalcman. The network helps show where Steven Zalcman may publish in the future.

Co-authorship network of co-authors of Steven Zalcman

This figure shows the co-authorship network connecting the top 25 collaborators of Steven Zalcman. A scholar is included among the top collaborators of Steven Zalcman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Zalcman. Steven Zalcman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Green, Michael F., Keith H. Nuechterlein, James M. Gold, et al.. (2004). Approaching a consensus cognitive battery for clinical trials in schizophrenia: The NIMH-MATRICS conference to select cognitive domains and test criteria. Biological Psychiatry. 56(5). 301–307. 702 indexed citations breakdown →

Charney, Dennis S., David H. Barlow, Kelly N. Botteron, et al.. (2002). Neuroscience research agenda to guide development of a pathophysiologically based classification system.. 87 indexed citations

Kirch, Darrell G., Llewellyn B. Bigelow, Esa R. Korpi, et al.. (1988). Serum Haloperidol Concentration and Clinical Response in Schizophrenia. Schizophrenia Bulletin. 14(2). 283–289. 17 indexed citations

Ko, Grant N., Esa R. Korpi, William J. Freed, Steven Zalcman, & Llewellyn B. Bigelow. (1985). Effect of valproic acid on behavior and plasma amino acid concentrations in chronic schizophrenic patients. Biological Psychiatry. 20(2). 209–215. 23 indexed citations

Knesevich, John W., Steven Zalcman, & Paula J. Clayton. (1983). Six-year follow-up of patients with carefully diagnosed good- and poor- prognosis schizophrenia. American Journal of Psychiatry. 140(11). 1507–1510. 10 indexed citations

Jeste, Dilip V., Steven Zalcman, Daniel R. Weinberger, et al.. (1983). Apomorphine response and subtyping of schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 7(1). 83–88. 19 indexed citations

Jeste, Dilip V., Lynn E. DeLisi, Steven Zalcman, et al.. (1981). A biochemical study of tardive dyskinesia in young male patients. Psychiatry Research. 4(3). 327–331. 29 indexed citations

Zalcman, Steven, et al.. (1981). Muscarinic cholinergic binding sites on intact human lymphocytes. Life Sciences. 29(1). 69–73. 48 indexed citations

Luchins, Daniel J., E. Fuller Torrey, Daniel R. Weinberger, et al.. (1980). HLA Antigens in Schizophrenia: Differences between Patients with and without Evidence of Brain Atrophy. The British Journal of Psychiatry. 136(3). 243–248. 31 indexed citations

10.

DeLisi, Lynn E., et al.. (1980). Lymphocyte monoamine oxidase activity and chronic schizophrenia. Psychiatry Research. 2(2). 179–186. 15 indexed citations

11.

DeLisi, L. E., C. David Wise, Steven G. Potkin, et al.. (1980). Dopamine-beta-hydroxylase, monoamine oxidase, and schizophrenia.. PubMed. 15(6). 895–907. 16 indexed citations

12.

Zalcman, Steven. (1975). The Marihuana Conviction: A History of Marihuana Prohibition in the United States. JAMA. 232(2). 194–194. 15 indexed citations

13.

Zalcman, Steven, Barry I. Liskow, Remi J. Cadoret, & Donald W. Goodwin. (1973). Marijuana and Amphetamine: The Question of Interaction. American Journal of Psychiatry. 130(6). 707–708. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact